Clinical Trial Update: A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants [Phase 4]

View source ↗

Summary

Phase 4 safety study of Sabin Inactivated Poliovirus Vaccine in infants completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Sabin Inactivated Poliovirus Vaccine (inactivated poliovirus vaccine (Sabin strain))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED